Actively Recruiting
LEARNER- Low dosE AspiRiN prEterm tRial (Angola)
Led by Instituto Nacional de Investigacao em Saude, Angola · Updated on 2024-05-16
450
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
Sponsors
I
Instituto Nacional de Investigacao em Saude, Angola
Lead Sponsor
F
FUNDACIÓN BANCARIA CAIXA D'ESTALVIS I PENSIONS DE BARCELONA
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gestational period.
CONDITIONS
Official Title
LEARNER- Low dosE AspiRiN prEterm tRial (Angola)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women with Sickle Cell Disease aged 15 years and older
- Attending Maternidade Lucrecia Paim, Hospital Materno Infantil Dr. Manuel Pedro Azancot de Menezes, or nearby health facilities
- Willing to attend regular consultations and consent to participate in the study
You will not qualify if you...
- Pregnant women with Sickle Cell Disease in the third trimester (after week 27)
- HIV infection
- Diabetes mellitus
- Chronic hypertension
- Liver disease with lab values 3 times above normal
- Sickle nephropathy
- Multiple pregnancies
- Hypersensitivity to aspirin
- History of blood transfusion in the last 3 months
- Did not consent to participate in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Instituto Nacional de Investigação Em Saúde
Luanda, Angola, 00000
Actively Recruiting
Research Team
T
TATIANA GOMES, BA/BS/Pre-MD
CONTACT
H
HELENA TEIXEIRA, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here